Vishal Kapoor - 16 Feb 2023 Form 3/A - Amendment Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
3/A - Amendment
Filing time
27 Feb 2023, 19:35:19 UTC
Date Of Original Report
17 Feb 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JSPR Voting Common Stock 43,750 16 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were inadvertently omitted from the Reporting Person's original Form 3 filed on February 17, 2023.